227 related articles for article (PubMed ID: 28780922)
1. Post-transplant lymphoproliferative disease is associated with early sternotomy and left ventricular hypoplasia during infancy: a population-based retrospective review.
Ekman-Joelsson BM; Wåhlander H; Synnergren M; Sager M; Mellgren K
Cardiol Young; 2017 Nov; 27(9):1823-1831. PubMed ID: 28780922
[TBL] [Abstract][Full Text] [Related]
2. Transplantation for congenital heart disease is associated with an increased risk of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in children.
Offor UT; Bacon CM; Roberts J; Powell J; Brodlie M; Wood K; Windebank KP; Flett J; Hewitt T; Rand V; Hasan A; Parry G; Gennery AR; Reinhardt Z; Bomken S
J Heart Lung Transplant; 2021 Jan; 40(1):24-32. PubMed ID: 33339556
[TBL] [Abstract][Full Text] [Related]
3. Post-transplant lymphoproliferative disorder in pediatric heart transplant recipients.
Manlhiot C; Pollock-Barziv SM; Holmes C; Weitzman S; Allen U; Clarizia NA; Ngan BY; McCrindle BW; Dipchand AI
J Heart Lung Transplant; 2010 Jun; 29(6):648-57. PubMed ID: 20304682
[TBL] [Abstract][Full Text] [Related]
4. Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.
Wasson S; Zafar MN; Best J; Reddy HK
J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):77-83. PubMed ID: 16703222
[TBL] [Abstract][Full Text] [Related]
5. Post-transplant lymphoproliferative disorder following pediatric heart transplantation.
Mendoza F; Kunitake H; Laks H; Odim J
Pediatr Transplant; 2006 Feb; 10(1):60-6. PubMed ID: 16499589
[TBL] [Abstract][Full Text] [Related]
6. Posttransplant lymphoproliferative disorder after liver and kidney transplant.
Akar Özkan E; Özdemir BH; Deniz EE; Tunca MZ; Haberal M
Exp Clin Transplant; 2014 Mar; 12 Suppl 1():142-8. PubMed ID: 24635813
[TBL] [Abstract][Full Text] [Related]
7. [Post-transplantation lymphoproliferative disorder in childhood].
Stréhn A; Szőnyi L; Kriván G; Kovács L; Reusz G; Szabó A; Rényi I; Kovács G; Dezsőfi A
Orv Hetil; 2014 Feb; 155(8):313-8. PubMed ID: 24534879
[TBL] [Abstract][Full Text] [Related]
8. Post-transplant lymphoproliferative disorder after liver transplantation: Incidence, long-term survival and impact of serum tacrolimus level.
Eshraghian A; Imanieh MH; Dehghani SM; Nikeghbalian S; Shamsaeefar A; Barshans F; Kazemi K; Geramizadeh B; Malek-Hosseini SA
World J Gastroenterol; 2017 Feb; 23(7):1224-1232. PubMed ID: 28275302
[TBL] [Abstract][Full Text] [Related]
9. Role of immunosuppression regimen in post-transplant lymphoproliferative disorder in pediatric heart transplant patients.
Dayton JD; Richmond ME; Weintraub RG; Shipp AT; Orjuela M; Addonizio LJ
J Heart Lung Transplant; 2011 Apr; 30(4):420-5. PubMed ID: 21147001
[TBL] [Abstract][Full Text] [Related]
10. Palliated Hypoplastic Left Heart Syndrome Patients Experience Superior Waitlist and Comparable Post-Heart Transplant Survival to Non-Single Ventricle Congenital Heart Disease Patients.
Greenberg JW; Raees MA; Dani A; Heydarian HC; Chin C; Zafar F; Lehenbauer DG; Morales DLS
Semin Thorac Cardiovasc Surg; 2024 Summer; 36(2):230-241. PubMed ID: 36455711
[TBL] [Abstract][Full Text] [Related]
11. Post-transplant lymphoproliferative syndrome in the pediatric liver transplant population.
Molmenti EP; Nagata DE; Roden JS; Squires RH; Molmenti H; Fasola CG; Winick N; Tomlinson G; Lopez MJ; D'Amico L; Dyer HL; Savino AC; Sanchez EQ; Levy MF; Goldstein RM; Andersen JA; Klintmalm GB
Am J Transplant; 2001 Nov; 1(4):356-9. PubMed ID: 12099380
[TBL] [Abstract][Full Text] [Related]
12. Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations.
Walker RC; Paya CV; Marshall WF; Strickler JG; Wiesner RH; Velosa JA; Habermann TM; Daly RC; McGregor CG
J Heart Lung Transplant; 1995; 14(2):214-21. PubMed ID: 7779838
[TBL] [Abstract][Full Text] [Related]
13. Composite risk factors predict survival after transplantation for congenital heart disease.
Kavarana MN; Savage A; O'Connell R; Rubinstein CS; Flynn-Reeves J; Joshi K; Stroud MR; Ikonomidis JS; Bradley SM
J Thorac Cardiovasc Surg; 2013 Oct; 146(4):888-93. PubMed ID: 23886031
[TBL] [Abstract][Full Text] [Related]
14. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
Schubert S; Renner C; Hammer M; Abdul-Khaliq H; Lehmkuhl HB; Berger F; Hetzer R; Reinke P
J Heart Lung Transplant; 2008 Jan; 27(1):100-5. PubMed ID: 18187094
[TBL] [Abstract][Full Text] [Related]
15. Determination of risk factors for Epstein-Barr virus-associated posttransplant lymphoproliferative disorder in pediatric liver transplant recipients using objective case ascertainment.
Guthery SL; Heubi JE; Bucuvalas JC; Gross TG; Ryckman FC; Alonso MH; Balistreri WF; Hornung RW
Transplantation; 2003 Apr; 75(7):987-93. PubMed ID: 12698085
[TBL] [Abstract][Full Text] [Related]
16. Abdominal involvement in pediatric heart and lung transplant recipients with posttransplant lymphoproliferative disease increases the risk of mortality.
Tai CC; Curtis JL; Szmuszkovicz JR; Horn MV; Ford HR; Woo MS; Wang KS
J Pediatr Surg; 2008 Dec; 43(12):2174-7. PubMed ID: 19040929
[TBL] [Abstract][Full Text] [Related]
17. Case-control study of risk factors for the development of post-transplant lymphoproliferative disease in a pediatric heart transplant cohort.
Katz BZ; Pahl E; Crawford SE; Kostyk MC; Rodgers S; Seshadri R; Proytcheva M; Pophal S
Pediatr Transplant; 2007 Feb; 11(1):58-65. PubMed ID: 17239124
[TBL] [Abstract][Full Text] [Related]
18. Post-transplant lymphoproliferative disorders: improved outcome after clinico-pathologically tailored treatment.
Muti G; Cantoni S; Oreste P; Klersy C; Gini G; Rossi V; D'Avanzo G; Comoli P; Baldanti F; Montillo M; Nosari A; Morra E;
Haematologica; 2002 Jan; 87(1):67-77. PubMed ID: 11801467
[TBL] [Abstract][Full Text] [Related]
19. Post-transplant lymphoproliferative disease presenting as a mass in the left ventricle in a heart transplant recipient at long-term follow-up.
Palma JH; Guilhen JC; Gaia DF; Teles A; Teles CA; Branco JN; Buffolo E
J Heart Lung Transplant; 2009 Feb; 28(2):206-8. PubMed ID: 19201350
[TBL] [Abstract][Full Text] [Related]
20. Imaging findings in children with proliferative disorders following multivisceral transplantation.
Hryhorczuk AL; Kim HB; Harris MH; Vargas SO; Zurakowski D; Lee EY
Pediatr Radiol; 2015 Jul; 45(8):1138-45. PubMed ID: 25796382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
